Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer

Clinical trial NCT00118235 · COMPLETED

Trial details

NCT number: NCT00118235
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer

Start date: 2004-12-01
Primary completion: 2007-04-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.